ChemoCentryx reported 5.47M in Stock for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Stock Change
Alnylam Pharmaceuticals ALNY:US $ 88.98M 10.46M
Amgen AMGN:US $ 4554M 143M
Bayer BAYN:GR € 11371M 502M
Biogen BIIB:US $ 1294.2M 78.8M
Biomarin Pharmaceutical BMRN:US $ 802.32M 15.96M
Bristol Myers Squibb BMY:US $ 2142M 38M
ChemoCentryx CCXI:US 5.47M 2.58M
GlaxoSmithKline GSK:LN 4664M 1339M
Macrogenics MGNX:US $ 2.95M 1.65M
Novartis NOVN:VX SF 6880M 117M
Sarepta Therapeutics SRPT:US $ 208.1M 9.1M
Takeda 4502:JP Y 927511M 74344M
Teva Pharmaceutical TEVA:IT 4.05B 37M
YTE INCY:US $ 54.5M 19.05M